Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids.
Tadashi ImafukuHiroshi WatanabeTakao SatohTakashi MatsuzakaTomoaki InazumiHiromasa KatoShoma TanakaYuka NakamuraTakehiro NakanoKai TokumaruHitoshi MaedaAyumi MukunokiToru TakeoNaomi NakagataMotoko TanakaKazutaka MatsushitaSoken TsuchiyaYukihiko SugimotoHitoshi ShimanoMasafumi FukagawaToru MaruyamaPublished in: Kidney360 (2020)
perturbation of renal FAs through induction of Elovl6. The perturbation of renal FAs induced by the AOPPs-Elovl6 system could be a potential target for the treatment of tubulopathy.